JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131450

Anti-CDK1 antibody

5

(4 Reviews)

|

(34 Publications)

Rabbit Polyclonal CDK1 antibody. Suitable for ICC/IF, WB, IHC-P and reacts with Human samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human CDK1 aa 1-50 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

CDC2, CDC28A, CDKN1, P34CDC2, CDK1, Cyclin-dependent kinase 1, Cell division control protein 2 homolog, Cell division protein kinase 1, p34 protein kinase

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-CDK1 antibody (AB131450)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CDK1 antibody (AB131450)

Immunofluorescent analysis of methanol fixed HeLa cells labelling CDK1 with ab131450 antibody at a dilution of 1/100.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody (AB131450)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody (AB131450)

Immunohistochemical analysis of paraffin embedded Human breast carcinoma tissue labelling CDK1 with ab131450 at 1/50 dilution. The image on the right is treated with the synthesized peptide.

Western blot - Anti-CDK1 antibody (AB131450)
  • WB

Unknown

Western blot - Anti-CDK1 antibody (AB131450)

All lanes:

Western blot - Anti-CDK1 antibody (ab131450) at 1/500 dilution

Lane 1:

HeLa cell extracts

Lane 2:

MCF cell extracts

Predicted band size: 34 kDa

false

Western blot - Anti-CDK1 antibody (AB131450)
  • WB

CiteAb

Western blot - Anti-CDK1 antibody (AB131450)

CDK1 western blot using anti-CDK1 antibody ab131450. Publication image and figure legend from Liu, Y., Li, L., et al., 2020, J Ovarian Res, PubMed 32414422.

ab131450 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab131450 please see the product overview.

Upregulation of CDK1 was observed after the overexpression of TONSL-AS1. The effects of overexpression of TONSL-AS1 and miR-490-3p on the expression of CDK1 mRNA (Fig. 3a) and protein (Fig. 3b) in OVCAR3 cells were analyzed by qPCR and western blot, respectively. Experiments were repeated 3 times and data were expressed as mean values, *, p < 0.05

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB, ICC/IF

applications

Immunogen

Synthetic Peptide within Human CDK1 aa 1-50 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P06493

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab131450 was purified by affinity chromatography using epitope specific peptide.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition via association with multiple interphase cyclins (PubMed : 16407259, PubMed : 16933150, PubMed : 17459720, PubMed : 18356527, PubMed : 19509060, PubMed : 19917720, PubMed : 20171170, PubMed : 20935635, PubMed : 20937773, PubMed : 21063390, PubMed : 2188730, PubMed : 23355470, PubMed : 2344612, PubMed : 23601106, PubMed : 23602554, PubMed : 25556658, PubMed : 26829474, PubMed : 27814491, PubMed : 30139873, PubMed : 30704899). Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, KAT5, LMNA, LMNB, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MLST8, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, TPPP, UL40/R2, RAB4A, RAP1GAP, RBBP8/CtIP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SAMHD1, SIRT2, CGAS and RUNX2 (PubMed : 16407259, PubMed : 16933150, PubMed : 17459720, PubMed : 18356527, PubMed : 19202191, PubMed : 19509060, PubMed : 19917720, PubMed : 20171170, PubMed : 20935635, PubMed : 20937773, PubMed : 21063390, PubMed : 2188730, PubMed : 23355470, PubMed : 2344612, PubMed : 23601106, PubMed : 23602554, PubMed : 25556658, PubMed : 26829474, PubMed : 27814491, PubMed : 30704899, PubMed : 32351706, PubMed : 34741373). CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs (PubMed : 18480403, PubMed : 20360007). Essential for early stages of embryonic development (PubMed : 18480403, PubMed : 20360007). During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation (PubMed : 18480403, PubMed : 20360007, PubMed : 2188730, PubMed : 2344612, PubMed : 30139873). Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis (PubMed : 18480403, PubMed : 20360007). Phosphorylates KRT5 during prometaphase and metaphase (By similarity). Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair (PubMed : 20360007). Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression (PubMed : 20395957). Catalyzes lamin (LMNA, LMNB1 and LMNB2) phosphorylation at the onset of mitosis, promoting nuclear envelope breakdown (PubMed : 2188730, PubMed : 2344612, PubMed : 37788673). In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons (PubMed : 18356527). The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis (PubMed : 16371510). NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation (PubMed : 19509060). In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis (PubMed : 20171170). The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis (PubMed : 19917720). In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis (PubMed : 20937773). This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes (PubMed : 20937773). EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing (PubMed : 20935635). CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration (By similarity). CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis (PubMed : 26549230). Regulates the amplitude of the cyclic expression of the core clock gene BMAL1 by phosphorylating its transcriptional repressor NR1D1, and this phosphorylation is necessary for SCF(FBXW7)-mediated ubiquitination and proteasomal degradation of NR1D1 (PubMed : 27238018). Phosphorylates EML3 at 'Thr-881' which is essential for its interaction with HAUS augmin-like complex and TUBG1 (PubMed : 30723163). Phosphorylates CGAS during mitosis, leading to its inhibition, thereby preventing CGAS activation by self DNA during mitosis (PubMed : 32351706). Phosphorylates SKA3 on multiple sites during mitosis which promotes SKA3 binding to the NDC80 complex and anchoring of the SKA complex to kinetochores, to enable stable attachment of mitotic spindle microtubules to kinetochores (PubMed : 28479321, PubMed : 31804178, PubMed : 32491969).. (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry.
See full target information CDK1

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Food science & nutrition 13:e70215 PubMed40336533

2025

Suppression of Cellular Proliferation in PC3 Prostate Cancer Cells by Green Tea Extract Through Induction of miR-34a Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Seyedeh Fatemeh Soghrati Salek Moalemi,Fatemeh Safari,Hiva Ahvati

MedComm 5:e711 PubMed39286779

2024

A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Ding,Jianghong Cai,Li Jin,Wei Hu,Wu Song,Peter Rose,Zhiyuan Tang,Yangyang Zhan,Leilei Bao,Wei Lei,Yi Zhun Zhu

BMC cancer 24:1099 PubMed39232721

2024

Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model.

Applications

Unspecified application

Species

Unspecified reactive species

Nastaran Afsordeh,Safura Pournajaf,Hadi Bayat,Fatemeh Mohajerani,Amir Shojaei,Javad Mirnajafi-Zadeh,Mohammad Hossein Pourgholami

Nature communications 15:3793 PubMed38714822

2024

An interphase actin wave promotes mitochondrial content mixing and organelle homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Stephen M Coscia,Andrew S Moore,Cameron P Thompson,Christian F Tirrito,E Michael Ostap,Erika L F Holzbaur

Cell reports. Medicine 4:101224 PubMed37797616

2023

Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer.

Applications

Unspecified application

Species

Unspecified reactive species

YongHwan Kim,Hyein Ju,Seung-Yeon Yoo,Jinahn Jeong,Jinbeom Heo,Seungun Lee,Ja-Min Park,Sun Young Yoon,Se Un Jeong,Jinyoung Lee,HongDuck Yun,Chae-Min Ryu,Jinah Lee,Yun Ji Nam,Hyungu Kwon,Jaekyoung Son,Gowun Jeong,Ji-Hye Oh,Chang Ohk Sung,Eui Man Jeong,Jaehoon An,Sungho Won,Bumsik Hong,Jae Lyun Lee,Yong Mee Cho,Dong-Myung Shin

Molecular therapy. Nucleic acids 33:910-924 PubMed37680988

2023

Expression of correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Catarina Alves-Vale,Ana Maria Capela,Carlota Tavares-Marcos,Beatriz Domingues-Silva,Bruno Pereira,Francisco Santos,Carla Pereira Gomes,Guadalupe Espadas,Rui Vitorino,Eduard Sabidó,Paula Borralho,Sandrina Nóbrega-Pereira,Bruno Bernardes de Jesus

Experimental & molecular medicine 54:801-811 PubMed35729325

2022

The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jinbeom Heo,Jinyoung Lee,Yun Ji Nam,YongHwan Kim,HongDuck Yun,Seungun Lee,Hyein Ju,Chae-Min Ryu,Seon Min Jeong,Jinwon Lee,Jisun Lim,Yong Mee Cho,Eui Man Jeong,Bumsik Hong,Jaekyoung Son,Dong-Myung Shin

Oncology letters 24:261 PubMed35765271

2022

MicroRNA-409-5p inhibits cell proliferation, and induces G/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Weiwei Li,Ji Lin,Jianfen Huang,Zhuoying Chen,Qunying Sheng,Fang Yang,Xue Yang,Xiaojie Cui

Molecular cancer research : MCR 20:1379-1390 PubMed35612556

2022

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Atsushi Fushimi,Yoshihiro Morimoto,Satoshi Ishikawa,Nami Yamashita,Atrayee Bhattacharya,Tatsuaki Daimon,Hasan Rajabi,Caining Jin,Masayuki Hagiwara,Yota Yasumizu,Zhou Luan,Wenhao Suo,Kwok-Kin Wong,Henry Withers,Song Liu,Mark D Long,Donald Kufe

Neoplasma 69:807-819 PubMed35471977

2022

Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Min Yuan,Xian-Ling Guo,Jian-Hua Chen,Yang He,Zhu-Qing Liu,He-Ping Zhang,Jie Ren,Qing Xu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com